Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
In multiple myeloma (MM), hemostatic disorders such as thrombocytopenia, coagulopathies, and thrombophilia are well-documented. These abnormalities can be partially attributed to therapy, including thrombocytopenia following treatment with proteasome inhibitors such as bortezomib and carfilzomib or...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2025-03-01
|
| Серии: | Frontiers in Hematology |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/frhem.2025.1435193/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|